MPS Limited has informed the Exchange about a conference call on Wednesday, 18 February 2026, on the acquisition of Unbound Medicine Inc., USA.
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MPS Limited has announced a conference call scheduled for Wednesday, 18 February 2026, to discuss its acquisition of Unbound Medicine Inc., a US-based company. The call will provide further details about the deal, its strategic rationale, and likely financial implications. Unbound Medicine is a digital health publishing and knowledge solutions company, which could expand MPS's footprint in the healthcare content and technology space. This is an investor communication ahead of or following a significant corporate action.
Investors should watch for details on deal value, funding, and expected revenue contribution. The acquisition could boost growth prospects but also carries integration and valuation risks depending on the price paid.